At the moment, FP&A in pharma is going through a complex period of change. While new technologies are making it easier to collect and analyze data, external factors are making it much harder to ...

As UK businesses increasingly embrace AI to streamline translation, a critical question arises: Can AI tools be trusted with confidential material?

We previously assessed transcriptional changes within tumor cells at residual disease (RD) after EGFR TKI treatment, which included a subset of samples obtained from patients enrolled in this ...